ArticleInvestigational new drugs2023

Cyclin-dependent kinase (CDK) 4/6 inhibition in non-small cell lung cancer with epidermal growth factor receptor (EGFR) mutations.

Atsushi Osoegawa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.